Ivosidenib is designed to target the IDH1 protein, It’s used for treating AML that comes back or doesn’t respond, particularly in cases with certain IDH1 gene changes. The drug helps cut down cancer cell growth by stopping this wonky IDH1 enzyme from doing its thing.
Ivosidenib comes in the form of 250 mg tablets with a film coating, The suggested amount is 500 mg per day, taken just once a day with food. Each bottle holds 60 tablets, So, a full treatment goes for about two bottles, which is 120 tablets, for a month.
Reviews
There are no reviews yet.